HAART initiation at CD4 cell counts of ≥ 200 cells/mm3 is associated with a decreased risk of anaemia, renal impairment and peripheral neuropathy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1626, 2008-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD4 cell counts a plus to guide therapy initiation

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

CD4+ cell counts show more improvement with early addition of interleukin-2 (IL-2) to HAART

By  

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cisplatin/etoposide: Renal impairment and peripheral neuropathy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Changes in blood counts from cycle 1 to cycle 2 appear to be associated with an increased risk of grade 3 or 4 toxicity

By  

Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Parecoxib can cause renal impairment, with multiple doses associated with a greater risk

By  

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite